Molecular imaging is a non-invasive way of visualising, characterising and studying the biological processes at the molecular and cellular levels in humans and other living systems. Unique insights obtained from various molecular imaging modalities such as magnetic resonance imaging (MRI), radiotracer imaging/nuclear medicine such as positron emission tomography (PET), optical imaging, photoacoustic tomography, ultrasound and others enable a better understanding of clinical biology of the disease process. This not only improves patient-care but also helps clinicians to provide personalised treatment. Molecular imaging has found various applications in the medical field especially in the diagnosis of cancer, neurological disorders and cardiovascular diseases.
The Thurecht Group is interested in measuring the efficacy of nanomaterials towards increasing the amount of accumulation at the target site and understanding drug release at the site of action, using different molecular imaging techniques.
List of Projects
